SCHEMBL4732770

SCHEMBL4732770

CNC1CCC(Cc2cc(-c3ccc(C(=O)C(F)(F)F)cc3)ccc2OC)(NC(=O)C(F)(F)F)CC1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MLYCD O95822 1/20 0.34
CNR1 P21554 1/20 0.34
BDKRB1 P46663 1/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
PDE4A P27815 2/20 0.33
PDE4B Q07343 2/20 0.33
PDE4C Q08493 2/20 0.33
PDE4D Q08499 2/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
EPHX2 P34913 2/20 0.32
NQO2 P16083 2/20 0.32
MTNR1A P48039 2/20 0.32
MTNR1B P49286 2/20 0.32
MAPK14 Q16539 1/20 0.32
RARB P10826 2/20 0.32
RARG P13631 2/20 0.32
RARA P10276 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4732364 0.91 SRD5A2 (0.35) CNR1BDKRB1MEN1KMT2ARARB
SCHEMBL4732313 0.90 KIF11 (0.38) ALDH1A1USP2TSHRSMN1; SMN2
SCHEMBL4733934 0.89 CNR1 (0.33) CNR1BDKRB1CYP1A2CYP2C9CYP2C19
SCHEMBL4735928 0.88 BDKRB1 (0.35) MLYCDCNR1BDKRB1
SCHEMBL4734506 0.88 CYP1A2 (0.32) CNR1BDKRB1CYP1A2CYP2C9CYP2C19
SCHEMBL4731162 0.86 CYP1A2 (0.31) CYP1A2CYP2C9CYP2C19NQO2MTNR1A
SCHEMBL4731912 0.85 ALDH1A1 (0.39) MEN1KMT2AKDM4EALDH1A1LMNA
SCHEMBL4734451 0.84 PDE4A (0.38) MLYCDMEN1KMT2APDE4APDE4B
SCHEMBL4730244 0.84 BDKRB1 (0.32) CNR1BDKRB1CYP1A2CYP2C9CYP2C19
SCHEMBL4735935 0.81 MTNR1B (0.38) CNR1BDKRB1MEN1KMT2ANQO2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8273747-B2 tert-Butyl (4-((4'-cyano-4-methoxy-biphenyl-3-ylmethyl)-amino)-cyclohexyl)-methyl-carbamate; hedgehog pathway agonists; alopecia; angiogenesis; wound healing; alzheimer's disease; inhibit aging effects on skin CURIS, INC. (US) 2012-09-25 US disclosed
US-20080193423-A1 Small organic molecule regulators of cell proliferation CURIS, INC. (US) 2008-08-14 US disclosed
US-20080194637-A1 Small organic molecule regulators of cell proliferation CURIS, INC. (US) 2008-08-14 US disclosed
US-20080182859-A1 tert-Butyl {4-[(4'-cyano-4-methoxy-biphenyl-3-ylmethyl)-amino]-cyclohexyl}-methyl-carbamate; hedgehog pathway agonists; to modulate proliferation or differentiation in a cell or tissue in vivo or vitro; alopecia; angiogenesis; wound healing; alzheimer's disease; to inhibit aging effects on skin CURIS, INC. (US) 2008-07-31 US disclosed
WO-2008057469-A1 SMALL ORGANIC MOLECULE REGULATORS OF CELL PROLIFERATION WYETH (US) 2008-05-15 WO disclosed
WO-2008057497-A2 SMALL ORGANIC MOLECULE REGULATORS OF CELL PROLIFERATION CURIS, INC. (US) 2008-05-15 WO disclosed
WO-2008057468-A1 SMALL ORGANIC MOLECULE REGULATORS OF CELL PROLIFERATION CURIS, INC. (US) 2008-05-15 WO disclosed
US-20080058521-A1 Processes for the preparation of compounds WYETH (US) 2008-03-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080193423-A1 Small organic molecule regulators of cell proliferation GLI1, SHH, SMO MLYCD 2001/4885CNR1 641/4885BDKRB1 3686/4885
US-20080058521-A1 Processes for the preparation of compounds MKI67, MCL1, DCX MLYCD 257/4885CNR1 2612/4885BDKRB1 3053/4885
US-20080194637-A1 Small organic molecule regulators of cell proliferation GLI1, SHH, SMO MLYCD 2001/4885CNR1 641/4885BDKRB1 3686/4885
US-20080182859-A1 tert-Butyl {4-[(4'-cyano-4-methoxy-biphenyl-3-ylmethyl)-amino]-cyclohexyl}-methyl-carbamate; hedgehog pathway agonists; to modulate proliferation or differentiation in a cell or tissue in vivo or vitro; alopecia; angiogenesis; wound healing; alzheimer's disease; to inhibit aging effects on skin SHH, GLI1, SMO MLYCD 1352/4885CNR1 217/4885BDKRB1 1010/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.